Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Capital Markets

Shenzhen Edge Medical / Equity Capital Markets

<ul>
<li>Shenzhen Edge Medical, a China-based surgical robotic company, launched its IPO to raise at least USD 154 million via a Hong Kong listing.</li>
<li>In this note, we look at the deal terms and provide a valuation for the company.</li>
<li>We think the deal is well timed when its comparable peer performed well.</li>
</ul>


Shenzhen Edge Medical, a China-based surgical robotic company, launched its IPO to raise at least USD 154 million via a Hong Kong listing.
In this note, we look at the deal terms and provide a valuation for the company.
We think the deal is well timed when its comparable peer performed well.


Shenzhen Edge Medical (精锋医疗) IPO: Well-Timed Launch Supports Valuation

<ul>
<li>Shenzhen Edge Medical, a China-based surgical robotic company, is seeking to raise at least USD 100 million via a Hong Kong listing. MS and GF are the joint book runners.</li>
<li>In this note, we look at the company’s main product, MP1000, and assess the selling point and the market dynamics.</li>
<li>We also look at the company’s management experiences and pre-IPO investors.</li>
</ul>


Shenzhen Edge Medical, a China-based surgical robotic company, is seeking to raise at least USD 100 million via a Hong Kong listing. MS and GF are the joint book runners.
In this note, we look at the company’s main product, MP1000, and assess the selling point and the market dynamics.
We also look at the company’s management experiences and pre-IPO investors.


Shenzhen Edge Medical (精锋医疗) Pre-IPO: Fast Follower, Competition Is Intense

Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>
<a href="https://smartkarma.com/entities/shenzhen-edge-medical-co-ltd">Shenzhen Edge Medical</a> is a leading Chinese surgical robotics company, notable for being the first in China and second globally to have multi-port, single-port, and bronchoscopy surgical robots approved for market launch.</li>
  <li>The company is strategically positioned to capitalize on the rapidly growing but under-penetrated surgical robotics market in China, which is supported by strong government initiatives and increasing healthcare demand.</li>
  <li>Despite its technological advancements and strong investor backing, the company is in its pre-revenue stage, facing significant net losses due to high R&amp;D expenditure and intense competition from both domestic and international players.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  
Shenzhen Edge Medical is a leading Chinese surgical robotics company, notable for being the first in China and second globally to have multi-port, single-port, and bronchoscopy surgical robots approved for market launch.
  The company is strategically positioned to capitalize on the rapidly growing but under-penetrated surgical robotics market in China, which is supported by strong government initiatives and increasing healthcare demand.
  Despite its technological advancements and strong investor backing, the company is in its pre-revenue stage, facing significant net losses due to high R&amp;D expenditure and intense competition from both domestic and international players.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Shenzhen Edge Medical (SEM HK) - Nov 2025

HK/China Equity Long-Short

Osbert Tang, CFA

Thematic (Sector/Industry)

<ul>
<li>The collapse of the US markets on Friday, following better-than-expected nonfarm payrolls in May, is expected to send the Asian markets into panic on Monday.</li>
<li>The IPOs in Hong Kong this year are vulnerable, especially those that performed well, like <a href="https://www.smartkarma.com/entities/knowledge-atlas-technology-joint-stock-company-limited-class-h" target="_blank" data-smartkarma-citation="entities:44500:1" rel="noopener">Knowledge Atlas Technology (2513 HK)</a> and Beijing Deepzero Technology (2723 HK).</li>
<li>
<a href="https://www.smartkarma.com/entities/giga-device-semiconductor-inc-class-h" target="_blank" data-smartkarma-citation="entities:46238:1" rel="noopener">GigaDevice Semiconductor (3986 HK)</a>, <a href="https://www.smartkarma.com/entities/montage-technology-co-ltd-class-h" target="_blank" data-smartkarma-citation="entities:46333:1" rel="noopener">Montage Technology (6809 HK)</a>, and <a href="https://www.smartkarma.com/entities/minimax-group-inc" target="_blank" data-smartkarma-citation="entities:46185:1" rel="noopener">MiniMax (100 HK)</a> are also riskier names in the current market environment. </li>
</ul>


The collapse of the US markets on Friday, following better-than-expected nonfarm payrolls in May, is expected to send the Asian markets into panic on Monday.
The IPOs in Hong Kong this year are vulnerable, especially those that performed well, like Knowledge Atlas Technology (2513 HK) and Beijing Deepzero Technology (2723 HK).

GigaDevice Semiconductor (3986 HK), Montage Technology (6809 HK), and MiniMax (100 HK) are also riskier names in the current market environment. 


HK Strategy: The Imminent Sell-Off - What IPOs Are More Vulnerable?

Index Rebal/Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal/Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

<ul>
<li>The current HSTECH Index tracks the performance of the top 30 technology companies listed in Hong Kong that have high business exposure to certain technology themes.</li>
<li>A new methodology has been proposed and if implemented, index composition could change drastically in the next index rebal event.</li>
<li>There could be at least 20 changes to the index as the new methodology aims to increase index member count from 30 to 50 in December 2026.</li>
</ul>


The current HSTECH Index tracks the performance of the top 30 technology companies listed in Hong Kong that have high business exposure to certain technology themes.
A new methodology has been proposed and if implemented, index composition could change drastically in the next index rebal event.
There could be at least 20 changes to the index as the new methodology aims to increase index member count from 30 to 50 in December 2026.


Quiddity Leaderboard HSTECH Dec26: OLD Vs NEW Methodology; Mega Flows Possible

China

Edge Medical specializes in the design, development, manufacturing, and sale of advanced surgical robot systems, including multi-port and single-port endoscopic robots and bronchoscopy systems. The company aims to advance surgical technologies and deliver high-quality robotic solutions to healthcare institutions globally. It was founded in Shenzhen, China, on May 4, 2017.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Shenzhen Edge Medical (2675 HK)

Shenzhen Edge Medical (精锋医疗) IPO: Well-Timed Launch Supports Valuation

China's surgical robotic company, Shenzhen Edge Medical, launches IPO in Hong Kong to raise at least $154 million. We look at the deal terms and...

Ke Yan, CFA, FRM

Shenzhen Edge Medical (精锋医疗) Pre-IPO: Fast Follower, Competition Is Intense

China's Shenzhen Edge Medical plans to raise $100 million through a Hong Kong listing. We look at their surgical robotic product MP1000, market...

Ke Yan, CFA, FRM

Primer: Shenzhen Edge Medical (SEM HK) - Nov 2025

Shenzhen Edge Medical is a leading Chinese surgical robotics company, notable for being the first in China and second globally to have...

αSK Primers

HK Strategy: The Imminent Sell-Off - What IPOs Are More Vulnerable?

The US market collapse on Friday will trigger panic in Asian markets. HK IPOs like Knowledge Atlas, Beijing Deepzero, GigaDevice Semiconductor,...

Osbert Tang, CFA

Quiddity Leaderboard HSTECH Dec26: OLD Vs NEW Methodology; Mega Flows Possible

There could be several high-impact additions in December 2026 if the newly proposed methodology is implemented. The one-way flow could be around...

Janaghan Jeyakumar, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Shenzhen Edge Medical (精锋医疗) IPO: Well-Timed Launch Supports Valuation

​China's surgical robotic company, Shenzhen Edge Medical, launches IPO in Hong Kong to raise at least $154 million. We look at the deal terms and...

Ke Yan, CFA, FRM

Shenzhen Edge Medical (精锋医疗) Pre-IPO: Fast Follower, Competition Is Intense

​China's Shenzhen Edge Medical plans to raise $100 million through a Hong Kong listing. We look at their surgical robotic product MP1000, market...

Ke Yan, CFA, FRM

Primer: Shenzhen Edge Medical (SEM HK) - Nov 2025

Shenzhen Edge Medical is a leading Chinese surgical robotics company, notable for being the first in China and second globally to have...

αSK Primers

HK Strategy: The Imminent Sell-Off - What IPOs Are More Vulnerable?

​The US market collapse on Friday will trigger panic in Asian markets. HK IPOs like Knowledge Atlas, Beijing Deepzero, GigaDevice Semiconductor,...

Osbert Tang, CFA

Quiddity Leaderboard HSTECH Dec26: OLD Vs NEW Methodology; Mega Flows Possible

There could be several high-impact additions in December 2026 if the newly proposed methodology is implemented. The one-way flow could be around...

Janaghan Jeyakumar, CFA

China's surgical robotic company, Shenzhen Edge Medical, launches IPO in Hong Kong to raise at least $154 million. We look at the deal terms and...

China's Shenzhen Edge Medical plans to raise $100 million through a Hong Kong listing. We look at their surgical robotic product MP1000, market...

The US market collapse on Friday will trigger panic in Asian markets. HK IPOs like Knowledge Atlas, Beijing Deepzero, GigaDevice Semiconductor,...